Pims

PIMS Technology is a French medical technology and diagnostics company that develops and manufactures patented laboratory equipment for patient stratification and personalized medicine. Spun off from Inoviem Scientific and operating as a subsidiary of ATON SA, the company's core offering is its Physiological Intermolecular Modulation Spectroscopy (PIMS) technology. This label-free, non-destructive biophysical platform analyzes dynamic protein-protein and protein-solvent interactions in patient-derived samples (such as blood or tissues) to generate a physiological fingerprint. By measuring real drug-patient interactions ex vivo, PIMS Technology's PIMS Q8 platform helps clinicians and pharmaceutical companies predict therapeutic response, select optimal clinical trial cohorts, and monitor treatment efficacy in real time, particularly in oncology and inflammatory bowel disease.